Pharmaceutical Preparations · DE · CIK 1360214
Harrow, Inc. provides branded ophthalmic disease management solutions and medications for eyecare professionals and patients
Comparable business profile · signals at a glance
In the 90 days to Mar 4, 2026: 1 sold $9.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 134,000 | $39.67 | $5.3M |
| Mar 4, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 4,263 | $39.67 | $169K |
| Mar 3, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 59,000 | $39.15 | $2.3M |
| Mar 3, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 1,309 | $39.15 | $51K |
| Feb 27, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 5,000 | $54.18 | $271K |
| Jan 6, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 20,000 | $53.35 | $1.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.